Aims: Highly Active Antiretroviral Therapy (HAART) is the current care standard for treating patients with HIV/AIDS. Although HAART has is the only regimen potent enough to decrease viral load, adverse events may limit its efficacy. Metabolic disorders are common in patients trea...
Open access
Research Article10.9734/jamps/2019/v21i130121
Aims: To evaluate the effect of an organotherapic drug, produced from the pancreas of a young pig, on glycemic alterations in AIDS patients. Methodology: Current study was carried out in a double-blind, placebo controlled and randomized design. AIDS patients who had high fasting...
Open access
Research Article10.9734/BJMMR/2015/14036
Aims: Changes in cytokine levels in HIV infected individuals can affect the function of the immune system and have the potential to directly impact the course of HIV disease by enhancing or suppressing HIV replication. Melatonin influences various immune cells, including lymphocy...
Open access
Research Article10.9734/jamps/2025/v27i4767
Background: Highly Active Antiretroviral Therapy (HAART) is associated with significant mortality decreased and risk in AIDS progression. However, complications due to long-standing HIV infection and treatment have become increasingly important. Complications include hepatic and...
Open access
Research Article10.9734/JOCAMR/2018/43701